http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013137404-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
| filingDate | 2012-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013137404-A |
| titleOfInvention | BIFIDOBACTERIUM BIFIDUM STRAINS FOR USE IN DISEASES OF THE GASTROINTESTINAL TRACT |
| abstract | 1. The strain Bifidobacterium bifidum or a mutant or variant for use as a probiotic in a food product and / or as a medicine, the strain being Bifidobacterium bifidum MIMBb75, deposited under registration number DSM 24514, or its mutant or variant. 2. The strain, mutant or variant according to claim 1 for use as a probiotic in the composition of a food product and / or as a medicine for the prevention and / or treatment of a disease associated with functional disorders of the gastrointestinal tract, with undesirable inflammatory activity, with an imbalance of microbiocenosis intestines, a decrease in the amount of Bifidobacteria in the gastrointestinal tract and / or impaired barrier function of the gastrointestinal tract, or for use to weaken, prevent and / or treat an abdo individual inalnoy pain, discomfort, bloating, flatulence, dyspepsia, fecal urgency and / or reduce and / or increase in frequency of stool, feeling of incomplete bowel evacuation and / or a combination thereof, or to improve the quality of life patsienta.3. The strain, mutant or variant according to claim 2, wherein the disease is selected from the group consisting of spastic colitis, inflammatory bowel disease, for example, Crohn’s disease or ulcerative colitis, irritable bowel syndrome, spider veins or post-infectious colitis, gastrointestinal cancer, systemic disease, such as rheumatoid arthritis, autoimmune diseases caused by unwanted inflammatory activity, diarrheal disease caused by unwanted inflammatory activity, such as diarrhea, caused by Naya Clostridium difficile, en |
| priorityDate | 2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.